Acute streptococcal myopericarditis mimicking myocardial infarction.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 18534319)

Published in Am J Emerg Med on June 01, 2008

Authors

Ali Khavandi1, John Whitaker, Andrew Elkington, Jo Probert, Paul R Walker

Author Affiliations

1: Department of Cardiology, Southmead Hospital, BS10 5NB Bristol, United Kingdom. khavandi@hotmail.com

Articles by these authors

Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy. Brain (2012) 1.92

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity (2005) 1.74

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med (2007) 1.64

Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors. Cancer Res (2007) 1.22

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol (2002) 1.11

Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells. J Immunol (2007) 1.08

Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol (2003) 1.07

Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res (2010) 1.07

B7-homolog 1 expression by human glioma: a new mechanism of immune evasion. Neuroreport (2005) 1.05

Towards higher specialist training. BMJ (2002) 0.98

Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo. J Virol (2004) 0.86

Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma. Glia (2010) 0.86

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain. J Immunol (2003) 0.86

Bicuspid aortic valve endocarditis complicated by mitral valve aneurysm. J Card Surg (2011) 0.86

Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators. FEBS Lett (2007) 0.86

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours. PLoS One (2013) 0.84

Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation? Neurology (2003) 0.84

Getting by with a little help from the right CD4(+) T cells. Oncoimmunology (2013) 0.83

Physical activity promotion among oncology nurses. Cancer Nurs (2012) 0.82

A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. Neuroreport (2002) 0.81

Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors. J Invest Dermatol (2006) 0.81

The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity. J Neuroinflammation (2013) 0.81

T-cell immunotherapy for malignant glioma: toward a combined approach. Curr Opin Oncol (2010) 0.80

Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. Cancer Biother Radiopharm (2008) 0.79

Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma. Immunol Lett (2002) 0.79

Percutaneous lead and system extraction in patients with cardiac resynchronization therapy (CRT) devices and coronary sinus leads. Pacing Clin Electrophysiol (2011) 0.79

Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue. Med J Aust (2008) 0.77

Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer. Cancer Biother Radiopharm (2006) 0.77

Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes. Glia (2008) 0.77

Percutaneous extraction of cardiac implantable electronic devices (CIEDs) in octogenarians. Pacing Clin Electrophysiol (2012) 0.76

Immunotherapy of Brain Tumors. Prog Tumor Res (2015) 0.76

Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer. Cancer Biother Radiopharm (2011) 0.75

Dilated cardiomyopathy and skeletal myopathy: presenting features of a laminopathy. BMJ Case Rep (2013) 0.75

Early experience. Br J Gen Pract (2009) 0.75

High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. Cancer Biother Radiopharm (2008) 0.75

Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2. Cancer Biother Radiopharm (2006) 0.75

Weighing projections of physical decline in lung cancer surgery decisions. Am J Med Sci (2015) 0.75

Novel MRI Technique Enables Non-Invasive Measurement of Atrial Wall Thickness. IEEE Trans Med Imaging (2017) 0.75

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies. Immunotherapy (2013) 0.75

Continuous infusion interleukin-2 and intravenous famotidine in metastatic melanoma. Cancer Biother Radiopharm (2006) 0.75

A high quality library service. J R Army Med Corps (2013) 0.75

Factors influencing poor visual outcome in patients treated with photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration. Clin Experiment Ophthalmol (2007) 0.75

Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells. J Invest Dermatol (2003) 0.75

An alarming symptom. J Prim Health Care (2013) 0.75